Table 1.
Characteristics1 | Discovery set (n =74) | Replication set (n =330) | P-value |
---|---|---|---|
Normal tissue (n) | 16 | — | |
Primary melanoma (not metastatic) (n) | 46 | 330 | |
Melanoma metastases (n) | 12 | — | |
Mean age, years (range)2 | 59.4 (20–92) | 54.5 (48–87) | 0.0072 |
Median Breslow thickness, mm (range) | 3 (0.6–19) | 2.45 (0.25–16.3) | 0.5898 |
Sex, no. (%) | 0.0916 | ||
Male | 33 (72%) | 183 (56%) | |
Female | 13 (28%) | 147 (44%) | |
Site, no. (%) | 0.2810 | ||
Head and neck | 10 (22%) | 35 (14%) | |
Trunk | 12 (26%) | 81 (32%) | |
Legs | 19 (41%) | 79 (32%) | |
Arms | 10 (22%) | 48 (19.2%) | |
Others3 | 0 | 7 (3%) | |
Not available | 0 | 80 | |
Melanoma type, no. (%) | 0.5897 | ||
Superficial spreading melanoma | 28 (61%) | 88 (64%) | |
Nodular melanoma | 8 (17%) | 26 (19%) | |
Acrolentiginous melanoma | 3 (7%) | 7 (5%) | |
Lentigo maligna melanoma | 1 (2%) | 2 (2%) | |
Desmoplastic melanoma | 1 (2%) | 1 (1%) | |
Nevoid melanoma | 0 | 1 (1%) | |
MIS | 2 (4%) | 0 | |
Unclassified | 0 | 0 | |
Others4 | 3 (7%) | 12 (9%) | |
Not available | 0 | 193 | |
AJCC stage at diagnosis | 0.2390 | ||
0 | 2 (4%) | 0 | |
I | 10 (22%) | 191 (69%) | |
II | 16 (36%) | 11 (4%) | |
III | 18 (40%) | 60 (22%) | |
IV | 0 | 14 (5%) | |
Not available | 0 | 54 | |
Ulceration, no. (%) | 0.2516 | ||
Absent | 28 (61%) | 83 (61%) | |
Present | 18 (39%) | 54 (39%) | |
Not available | 0 | 193 | |
Mitotic rate, no. per mm2 | — | ||
0 | 13 (28%) | — | |
1–6 | 19 (41%) | — | |
>6 | 13 (31%) | — | |
Not available | 0 | 330 | |
Median follow-up, days | 875 | 1,602 | <0.0001 |
Abbreviation: AJCC, American Joint Committee on Cancer.
The characteristics are presented for primary melanomas only.
Age of the patients calculated at the first biopsy.
Oral, male genital, and female vaginal location.
Polypoid, mucosal melanoma, spindle-cell melanoma, Spitz-type melanoma, and amelanotic melanoma.